Suppr超能文献

移植前肝脏保存:过去、现在与未来。

Liver preservation prior to transplantation: Past, present, and future.

作者信息

Chedid Marcio F, Pinto Marcelo A, Juchem Jose Felipe G, Grezzana-Filho Tomaz J M, Kruel Cleber R P

机构信息

Liver Transplant and Hepatobiliary Surgery Unit, Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre 90035-903, Brazil.

出版信息

World J Gastrointest Surg. 2019 Mar 27;11(3):122-125. doi: 10.4240/wjgs.v11.i3.122.

Abstract

Since Dr. Thomas Starzl performed the first series of successful liver transplants (LTs), important advances have been made in immunosuppression, operative techniques, and postoperative care. In 1988, Belzer's group reported the first successful LT using the University of Wisconsin preservation solution (UW). Since then, UW has replaced EuroCollins solution and allowed prolonged and safer preservation of liver, kidney, and pancreas allografts, thus contributing to the improvement of transplant outcomes. Although UW is still considered the standard of care in the United States and in several countries worldwide, a recent meta-analysis revealed similar LT outcomes among UW, Celsior solution, and the Institut Georges Lopez-1 preservation solution, which were slightly superior to those obtained with histidine-tryptophan-ketoglutarate preservation solution. Dynamic preservation has been recently developed, and liver allografts are preserved mainly through the following methods: hypothermic machine perfusion, normothermic machine perfusion, and subnormothermic machine perfusion. Their use has the potential advantage of improving clinical results in LT involving extended criteria donor allografts. Although associated with increased costs, techniques employing machine perfusion of liver allografts have been considered clinically feasible. This editorial focuses on recent advances and future perspectives in liver allograft preservation.

摘要

自托马斯·斯塔兹尔医生完成首例成功的肝移植手术以来,免疫抑制、手术技术及术后护理方面均取得了重大进展。1988年,贝尔泽团队报告了首例使用威斯康星大学保存液(UW)的成功肝移植手术。自那时起,UW已取代欧洲柯林斯液,使肝、肾及胰腺同种异体移植物得以更长时间且更安全地保存,从而推动了移植效果的改善。尽管UW在美国及全球多个国家仍被视为标准的护理方案,但最近一项荟萃分析显示,UW、赛而斯欧液及乔治·洛佩斯 -1研究所保存液的肝移植效果相似,略优于采用组氨酸 - 色氨酸 - 酮戊二酸保存液所获得的效果。动态保存技术最近得到了发展,肝同种异体移植物主要通过以下方法保存:低温机器灌注、常温机器灌注及亚常温机器灌注。它们的应用有可能改善涉及扩大标准供体同种异体移植物的肝移植临床效果。尽管与成本增加相关,但采用肝同种异体移植物机器灌注的技术已被认为在临床上是可行的。本社论聚焦于肝同种异体移植物保存的最新进展及未来前景。

相似文献

1
Liver preservation prior to transplantation: Past, present, and future.移植前肝脏保存:过去、现在与未来。
World J Gastrointest Surg. 2019 Mar 27;11(3):122-125. doi: 10.4240/wjgs.v11.i3.122.
10
Use of IGL-1 preservation solution in liver transplantation.IGL - 1保存液在肝移植中的应用。
Transplant Proc. 2014 Jul-Aug;46(6):1809-11. doi: 10.1016/j.transproceed.2014.05.040.

本文引用的文献

4
A randomized trial of normothermic preservation in liver transplantation.肝脏移植中常温保存的随机试验。
Nature. 2018 May;557(7703):50-56. doi: 10.1038/s41586-018-0047-9. Epub 2018 Apr 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验